Ildong wins latest round on ofloxacin ear drop

Ildong Pharm says that the patent dispute touched off by Daiichi Pharm of Japan fiver years ago against ofloxacin ear drop was substantially terminated by the recent ruling of the Supreme Court and that it may be able to market the antimicrobial agent in the domestic market.

In its ruling, the Supreme Court noted that the allegations on the part of Daiichi did not contain any novel elements,...